What is the best injection for weight loss in 2026?

The strongest published efficacy among FDA-approved weight loss injections is Zepbound (tirzepatide 15 mg) — ~20.9% mean body-weight loss at 72 weeks in SURMOUNT-1 (NEJM 2022). Wegovy (semaglutide 2.4 mg) produces ~14.9% at 68 weeks (STEP-1, NEJM 2021). SURMOUNT-5 (NEJM 2025) confirmed tirzepatide's edge in a head-to-head. Saxenda (liraglutide 3.0 mg) is older and produces ~5-8% at 56 weeks. 'Best' depends on tolerance, insurance coverage, and cost.

Can I get weight loss injections near me?

Yes — every major US retail pharmacy chain (CVS, Walgreens, Rite Aid, Costco, Sam's Club) dispenses FDA-approved weight loss injections with a valid prescription. Telehealth providers ship nationally. LillyDirect ships Zepbound vials directly via partner pharmacies. NovoCare ships Wegovy. Amazon Pharmacy offers same-day delivery in 3,000+ cities.

Are weight loss injections safe?

FDA-approved weight loss injections have a known published safety profile. Most common adverse reactions are gastrointestinal (nausea, vomiting, diarrhea, constipation, abdominal pain) and peak during dose escalation. Wegovy, Zepbound, and Saxenda all carry a thyroid C-cell tumor boxed warning based on rodent studies; clinical relevance to humans is debated. Documented concerns include gallbladder disease, pancreatitis, ileus, and potential muscle-mass loss with rapid weight loss.

What is the cheapest weight loss injection?

For brand-name FDA-approved injections, Wegovy through NovoCare self-pay at $299/month is the cheapest standard pen as of 2026-05-09. Zepbound vials through LillyDirect run $299-$449/month. Costco Member Prescription Program offers $349/month for Wegovy and Ozempic via the Sesame partner. With insurance and a copay savings card, both Wegovy and Saxenda can be as little as $25/month. Compounded semaglutide / tirzepatide from licensed 503A pharmacies typically run $99-$400/month but are not FDA-approved.

Are Ozempic and Mounjaro FDA-approved for weight loss?

No. Ozempic and Mounjaro are FDA-approved only for type 2 diabetes. Their identical active ingredients are sold under different brand names — Wegovy and Zepbound respectively — for the weight-management indication. Off-label prescribing of Ozempic or Mounjaro for weight loss is legal but typically not insurance-covered.

What is the difference between weight loss pills and weight loss injections?

In 2026 there are two FDA-approved oral GLP-1s (Foundayo, FDA-approved April 2026 for weight management; Rybelsus, for type 2 diabetes only) plus three older non-GLP-1 oral AOMs (Qsymia, Contrave, Xenical/alli). Injectable GLP-1s currently produce larger weight-loss effect sizes in published trials than the oral options, but Foundayo is too new for fair long-term comparison.

2026 Buyer's Guide

Weight Loss Injections (2026): Every FDA-Approved Option

Name: Weight Loss Injections — Complete Guide (2026)
Published: 2026-05-09

Five FDA-approved injectable medications can produce meaningful weight loss in 2026. Three (Wegovy, Zepbound, Saxenda) are FDA-approved specifically for chronic weight management. Two (Ozempic, Mounjaro) are FDA-approved for type 2 diabetes but commonly prescribed off-label for weight loss. Below: side-by-side comparison, how they work, what they cost, and where to get them.

By Eli Marsden · Founding Editor

Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed July 2026

9 min read·11 citations

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

About this page

Every drug listed below is FDA-approved with a published label on DailyMed (NIH). Mechanism, indication, administration route, dosing, and approval-date data are pulled from our primary-source-verified drug database. Cost data was verified live on July 2026 from manufacturer self-pay portals (NovoCare, LillyDirect), retailer programs (Costco Member Prescription Program via Sesame, Sam's Club Plus, Amazon Pharmacy), and GoodRx. We do not paraphrase indication language.

What are weight loss injections?

All five FDA-approved weight loss injections currently on the US market are GLP-1 receptor agonists (one is also a GIP/GLP-1 dual agonist). They are self-administered subcutaneous injections — a small needle into the fat layer of the abdomen, thigh, or back of the upper arm — and they reduce appetite via the GLP-1 signaling pathway plus slow gastric emptying. Three are FDA-approved for chronic weight management; two are FDA-approved for type 2 diabetes and prescribed off-label for weight loss when the weight-loss-indicated drugs are unavailable, denied by insurance, or contraindicated. The class history started with Byetta (exenatide) in 2005 for type 2 diabetes; Saxenda was the first weight-management indication in December 2014; Wegovy, Zepbound, and Foundayo followed.

For the deeper biology of GLP-1 — what the hormone is, how the receptor works, and the four physiologic actions (insulin secretion, glucagon suppression, gastric emptying, central appetite suppression) — see our GLP-1 complete guide. For oral weight loss medications (Foundayo, Rybelsus, Qsymia, Contrave, Xenical), see our FDA-approved weight loss medications hub (which compares pills vs injections side-by-side).

Every FDA-approved weight loss injection, compared

All five injections side-by-side. Pivotal trial efficacy cited from the canonical phase 3 publication for each drug; full PMID citations live in our bariatric vs GLP-1 decision guide.

Brand	Generic	Indication	Schedule	Pivotal trial result	Guide
Wegovy	Semaglutide 2.4 mg	Weight management; CV risk reduction	Once weekly (0.25 → 2.4 mg)	~14.9% body-weight loss at 68 wk (STEP-1, NEJM 2021)	Wegovy →
Zepbound	Tirzepatide	Weight management; OSA in obesity	Once weekly (2.5 → 15 mg)	~20.9% body-weight loss at 72 wk on 15 mg (SURMOUNT-1, NEJM 2022)	Zepbound →
Saxenda	Liraglutide 3 mg	Chronic weight management	Once-daily injection (0.6 → 3.0 mg titration)	~5-8% mean weight loss at 56 wk (SCALE Obesity / Prediabetes, PMID 26132939)	DailyMed →
Ozempic	Semaglutide (lower-dose)	Type 2 diabetes (off-label for weight loss)	Once weekly (0.25 → 2 mg)	A1C ↓ ~1.5-1.8% (SUSTAIN); ~12% off-label weight loss	Ozempic →
Mounjaro	Tirzepatide	Type 2 diabetes (off-label for weight loss)	Once weekly (2.5 → 15 mg)	A1C ↓ ~2.0-2.5% (SURPASS-2); ~15-22% off-label weight loss	Mounjaro →

What weight loss injections cost in 2026

Brand-name injection list prices range widely depending on channel. Verified live 2026-05-09 from manufacturer + retailer primary sources:

Wegovy (semaglutide)

NovoCare self-pay: $299/month (standard pen, all doses 0.25–2.4 mg)
NovoCare HD pen 7.2 mg: $399/month
Wegovy oral pill 1.5/4 mg: $149/month
Costco CMPP via Sesame: $349/month (new pt $199 × 2 mo)
Sam's Club: $499/month via copay program
With insurance copay savings card: as little as $25/month

Zepbound (tirzepatide)

LillyDirect vials self-pay (effective Dec 1, 2025): $299 / $399 / $449 by strength
LillyDirect KwikPen self-pay: $299–$699 by strength
Sam's Club KwikPen: $299/$399/$499/$699
GoodRx coupon path: $299/month (manufacturer-funded)

Saxenda (liraglutide)

Brand list: ~$1,300/month
Generic liraglutide (Teva, launched Aug 28 2025): pricing varies by pharmacy
Manufacturer copay savings card: as little as $25/month for commercially insured

Ozempic (off-label) + Mounjaro (off-label)

Ozempic NovoCare new patient: $199/mo for first 2 months; $349 standard
Ozempic GoodRx: $149/month (oral 1.5 mg) / pen via Novo
Mounjaro: no DTC self-pay program; copay savings card for commercial
Off-label use is rarely insurance-covered for weight loss when the patient does not have type 2 diabetes

For the live channel-by-channel pricing index across every channel + compounded options ($99–$400/mo), see our GLP-1 pricing index. Brand and compounded GLP-1s are generally HSA/FSA-eligible with a prescription per IRS Publication 502.

How to get a weight loss injection (telehealth, retail, insurance)

Three primary channels:

Insurance + traditional prescriber. Your PCP or an obesity-medicine specialist writes the prescription, your pharmacy fills it, your insurance applies the prior-authorization criteria. See our Cigna PA guide and Aetna PA guide for verbatim payer policy. The Cigna 11-condition comorbidity list, the Aetna 6-month behavioral-program requirement, and the CVS Caremark July 2025 Wegovy- preferred swap are the three things most prescribers under-document.
GLP-1 telehealth providers. Online clinic + 503A pharmacy partnership. Cash-pay compounded semaglutide / tirzepatide typically $99–$400/ month. See our best semaglutide providers and best tirzepatide providers for ranked options. Note: the FDA's enforcement-discretion grace period for compounded semaglutide ended February 2025 — the regulatory landscape is unsettled.
Direct-to-consumer manufacturer pharmacies. NovoCare (Wegovy/Ozempic), LillyDirect (Zepbound/ Mounjaro/Foundayo), Costco CMPP via Sesame partner, Sam's Club Plus, Amazon Pharmacy. Cash-pay only — not eligible for insurance.

Once you have the medication, follow the FDA-label injection technique. See our step-by-step injection technique guide for every common pen and vial format, including the three FDA-approved injection sites (abdomen, thigh, back of upper arm), needle gauge, depth, angle, and the site-rotation schedule that minimizes lipohypertrophy.

Compare vetted GLP-1 telehealth providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

No insurance needed · HSA/FSA eligible · vetted by our editors

6.9

Try Ageless

Lowest-tier compounded GLP-1 in injection, troche and sublingual forms

Starting price: $119/mo

Get started →Read review Try Ageless →

7.3

Sunlight

Compounded GLP-1 with unlimited telehealth visits and free shipping

Starting price: $159/mo

Get started →Read review Sunlight →

7.4

MadeMed

Compounded GLP-1 in both injection and oral forms

Starting price: $219/mo

Get started →Read review MadeMed →

8.3

Found

Mainstream telehealth GLP-1 access

Starting price: $99/mo

Get started →Read review Found →

7.4

Breeze Meds

Compounded GLP-1 access with named prescribers and 4-pharmacy network

Starting price: $199/mo

Get started →Read review Breeze Meds →

8.1

GobyMeds

Budget-conscious shoppers

Starting price: $159/mo

Get started →Read review GobyMeds →

Provider	Starting price	Best for
6.9Try Ageless	$119/mo	Lowest-tier compounded GLP-1 in injection, troche and sublingual forms	Get started →
7.3Sunlight	$159/mo	Compounded GLP-1 with unlimited telehealth visits and free shipping	Get started →
7.4MadeMed	$219/mo	Compounded GLP-1 in both injection and oral forms	Get started →
8.3Found	$99/mo	Mainstream telehealth GLP-1 access	Get started →
7.4Breeze Meds	$199/mo	Compounded GLP-1 access with named prescribers and 4-pharmacy network	Get started →
8.1GobyMeds	$159/mo	Budget-conscious shoppers	Get started →

Read review Try Ageless →Read review Sunlight →Read review MadeMed →Read review Found →Read review Breeze Meds →Read review GobyMeds →

Frequently Asked Questions

References

1.U.S. Food and Drug Administration / manufacturer label. Wegovy — FDA Prescribing Information (indication, dosing schedule, and boxed-warning language quoted verbatim from the current label). DailyMed, U.S. National Library of Medicine. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
2.U.S. Food and Drug Administration / manufacturer label. Zepbound — FDA Prescribing Information (indication, dosing schedule, and boxed-warning language quoted verbatim from the current label). DailyMed, U.S. National Library of Medicine. 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217806s000lbl.pdf
3.U.S. Food and Drug Administration / manufacturer label. Ozempic — FDA Prescribing Information (indication, dosing schedule, and boxed-warning language quoted verbatim from the current label). DailyMed, U.S. National Library of Medicine. 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209637lbl.pdf
4.U.S. Food and Drug Administration / manufacturer label. Mounjaro — FDA Prescribing Information (indication, dosing schedule, and boxed-warning language quoted verbatim from the current label). DailyMed, U.S. National Library of Medicine. 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf
5.U.S. Food and Drug Administration / Novo Nordisk label. Saxenda (liraglutide 3 mg) — FDA Prescribing Information (dosing ladder, indication, and boxed-warning language quoted verbatim from the current label). DailyMed, U.S. National Library of Medicine. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143
6.Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — ~20.9% mean body-weight reduction at 72 weeks (15 mg). New England Journal of Medicine. 2022. PMID: 35658024.
7.Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — ~14.9% mean body-weight reduction at 68 weeks (2.4 mg). New England Journal of Medicine. 2021. PMID: 33567185.
8.Garvey WT, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5) — head-to-head superiority of tirzepatide over semaglutide. New England Journal of Medicine. 2025. PMID: 40334173.
9.Pi-Sunyer X, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE Obesity and Prediabetes) — ~5-8% mean body-weight reduction at 56 weeks. New England Journal of Medicine. 2015. PMID: 26132939.
10.Novo Nordisk. NovoCare self-pay pricing for Wegovy and Ozempic — cash-pay pen pricing verified live July 2026. novocare.com. 2026. https://www.novocare.com/
11.Eli Lilly and Company. LillyDirect self-pay pricing for Zepbound single-dose vials — cash-pay vial pricing by strength verified live July 2026. lilly.com/lillydirect. 2026. https://lillydirect.lilly.com/